An investigation to identify the factors for negative sentinel lymph node metastasis in early breast cancer cases
Breast Cancer · 2026
DOI: 10.1007/s12282-026-01832-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Breast Cancer, 2026. Verfasst von Reiki Nishimura und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Sagara Hospital Miyazaki, Miyazaki City, Miyazaki, 880-0843, Japan. nishirei@ymail.ne.jp. Hauptthemen laut MEDLINE: Breast Neoplasms, Sentinel Lymph Node. Die Arbeit nennt 22 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Sentinel Lymph Node Biopsy (SLNB) in breast cancer (BC) is a standard procedure. Omission of SLNB in BC is an evolving area in clinical practice and a reasonable option. A retrospective study was conducted to identify cases of negative SLNs. METHODS: A total of 1,956 patients who underwent SLNB for cN0 invasive BC and who did not undergo preoperative chemotherapy were included in this retrospective study. Pathological diagnosis using frozen sections or the OSNA method was used for the diagnosis of SLNs. A multivariate analysis of factors for negative SLNs was performed using logistic regression analysis. RESULTS: Metastasis to SLNs was observed in 379 cases (19.4%). SLN metastasis was not associated with ER, PgR, and HER2 status. A multivariate analysis revealed that the significant factors for negative SLNs were age > 50 years, tumor size ≤ 2 cm and HG of 1. The incidence of SLN metastasis in Luminal B type was significantly higher than the other subtypes, and cases with breast conserving surgery had a significantly lower metastatic rate than total mastectomy. The disease-free survival rate of cases with the above-mentioned factors was favorable regardless of the SLN status. CONCLUSION: Metastasis to SLNs was found in 19.4% of cN0 BC cases. Factors related to negative SLNs were age > 50 years, tumor size ≤ 2cm, and HG of 1, and a positive SLN rate was significantly higher in the Luminal B subtype. The DFS for cases with the above factors was highly favorable. Therefore, conducting SLNB will depend on the above-mentioned characteristics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast Surgery, Sagara Hospital Miyazaki, Miyazaki City, Miyazaki, 880-0843, Japan. nishirei@ymail.ne.jp.
- Department of Breast Surgery, Fukuda Hospital, Social Medical Corporation Aiikukai, Kumamoto City, Japan. nishirei@ymail.ne.jp.
- Department of Breast Surgery, Sagara Hospital Miyazaki, Miyazaki City, Miyazaki, 880-0843, Japan.
- Department of Radiology, Sagara Hospital Miyazaki, Miyazaki City, Japan.
- Department of Pathology, Sagara Hospital Miyazaki, Miyazaki City, Japan.
- Department of Breast and Thyroid Surgical Oncology, Sagara Hospital, Social Medical Corporation Hakuaikai, Kagoshima City, Japan.
Zitieren
APA
Nishimura, R., Ueda, Y., Kiyohara, H., Funagayama, M., Ikeda, N., Kato, A., Tokiniwa, H., Higashi, R., Nakahara, M., Ifuku, H., Hayashi, T., Sagara, Y., Sagara, Y., & Ohno, S. (2026). An investigation to identify the factors for negative sentinel lymph node metastasis in early breast cancer cases. Breast Cancer. https://doi.org/10.1007/s12282-026-01832-9
Vancouver
Nishimura R, Ueda Y, Kiyohara H, Funagayama M, Ikeda N, Kato A, et al. An investigation to identify the factors for negative sentinel lymph node metastasis in early breast cancer cases. Breast Cancer. 2026. doi:10.1007/s12282-026-01832-9
BibTeX
@article{Nishimura2026,
author = {Nishimura, Reiki and Ueda, Yuichi and Kiyohara, Hiroshi and Funagayama, Mayumi and Ikeda, Naoko and Kato, Aya and Tokiniwa, Hideaki and Higashi, Ryutaro and Nakahara, Mayumi and Ifuku, Hiromi and Hayashi, Tohru and Sagara, Yasuaki and Sagara, Yoshiaki and Ohno, Shinji},
title = {An investigation to identify the factors for negative sentinel lymph node metastasis in early breast cancer cases},
journal = {Breast Cancer},
year = {2026},
doi = {10.1007/s12282-026-01832-9}
}
EUVIMED